#2017532
Feanasacuin
Fenazaquin
Filter results
Collections
30 results in 15 documents
#2092424
Feanascuin (F)
Fenazaquin (F)
#2154519
FEANASACUIN
FENAZAQUIN
#2359108
Feanasacuin
Fenazaquin
#2489919
Feanasacuin (F)
Fenazaquin (F)
#2739877
Feanasacuin
Fenazaquin
#3251558
Feanasacuin
Fenazaquin
#2092293
I gcás na haimeatochtraidine, na bicsifeine, na feanascuine, an spineatoram agus na teafluitrine, leagadh síos uasleibhéil iarmhar (MRLanna) i gCuid A d’Iarscríbhinn III a ghabhann le Rialachán (CE) Uimh. 396/2005.
For ametoctradin, bixafen, fenazaquin, spinetoram and tefluthrin maximum residue levels (MRLs) were set in Part A of Annex III to Regulation (EC) No 396/2005.
#2092305
I gcás na feanascuine, i gcomhréir le hAirteagal 12(1) de Rialachán (CE) Uimh. 396/2005, chuir an tÚdarás tuairim réasúnaithe isteach maidir leis na MRLanna atá ann cheana.
For fenazaquin the Authority submitted a reasoned opinion on the existing MRLs in accordance with Article 12(1) of Regulation (EC) No 396/2005.
#2092347
An tÚdarás Eorpach um Shábháilteacht Bia; Reasoned opinion on the review of the existing maximum residue levels for fenazaquin according to Article 12 of Regulation (EC) No 396/2005 [Tuairim réasúnaithe maidir leis an athbhreithniú ar na huasleibhéil iarmhar atá ann cheana le haghaidh na feanascuine de réir Airteagal 12 de Rialachán (CE) Uimh. 396/2005].
European Food Safety Authority; Reasoned opinion on the review of the existing maximum residue levels for fenazaquin according to Article 12 of Regulation (EC) No 396/2005.
#2092357
in Iarscríbhinn II, cuirtear isteach na colúin seo a leanas le haghaidh na haimeatochtraidine, na bicsifeine, na feanascuine, an spineatoram, na teafluitrine agus na tíoncarbasón-mheitile:
in Annex II, the following columns for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl are added:
#2092802
i gCuid A d’Iarscríbhinn III, scriostar na colúin le haghaidh na haimeatochtraidine, na bicsifeine, na feanascuine, an spineatoram agus na teafluitrine.
in Part A of Annex III, the columns for ametoctradin, bixafen, fenazaquin, spinetoram and tefluthrin are deleted.
#2489649
in Iarscríbhinn II, cuirtear an méid seo a leanas in áit na gcolún a bhaineann le beinsivindéfhluipir, boscailid, feanasacuin, fluasafop-P, fluipiridhéfhúrón, floscaipiorocsad, isifeitimíd, meataflumasón, pireaclóstróibin, spiriteitreamat, tiaibeandasól agus tolclófos-meitil:
in Annex II, the columns for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl are replaced by the following:
#2770906
Le Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún cuirtear síneadh le tréimhse formheasa na substaintí gníomhacha cleataidim, cioglocsaidim, dasaimeit, déchlófop, feanasacuin, himeacsasól, aigéad iondóiliolbútarach, meataildéad, agus paclabútrasól go dtí an 31 Bealtaine 2023.
Commission Implementing Regulation (EU) 2018/1266 extends the approval period of the active substances clethodim, cycloxydim, dazomet, diclofop, fenazaquin, hymexazol, indolylbutyric acid, metaldehyde and paclobutrazol until 31 May 2023.
#2770989
sa séú colún, dul in éag an fhormheasa, de ró 342, Feanasacuin, cuirtear “31 Lúnasa 2026” in ionad an dáta;
in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘31 August 2026’;
#2043262
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 maidir le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluometuron, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd (IO L 238, 21.9.2018, lch. 81).
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (OJ L 238, 21.9.2018, p. 81).
#2092287
lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar aimeatochtraidine, bhicsifeine, feanascuine, spineatoram, teafluitrine agus tíoncarbasón-mheitile i dtáirgí áirithe nó ar tháirgí áirithe
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl in or on certain products
#2383798
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluometuron, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide is to be incorporated into the EEA Agreement.
#2489610
lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products
#2489616
An 14 Nollaig 2021, ghlac an Coimisiún Codex Alimentarius uasteorainneacha iarmhair nua Codex (CXLanna) le haghaidh aicéiteaclóir, aifidipiripeine, beinsivindéfhluipire, défheintrine, boscailide, búpróifisine, cairbeandaisime, clórantrainileapróil, cioglainileapról, cipirmeitriní (lena n-áirítear alfa-cipirmeitrin agus zéite-cipirmeitrin), díceamba, feanascuine, floiniocaimíd, fluasafop-P, fluansulfóin, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, gliofosáite, isifeitimíd, creasocsaim-meitile, mandastróibine, méisitrí-óin, meataflumasóin, meataconasóil, meitipréine, peindémheatailine, peintiaipiorad, piococsastróibine, própaconasóil, pidhéfhluimeitifeine, pireaclóstróibine, pirióifeanóin, pireaprocsaifeine, spiriteitreamat, teabúconsóil, tiaibeandasóil, tolclófos-meitile agus toilfeinpioráide.
On 14 December 2021, the Codex Alimentarius Commission adopted new Codex maximum residue limits (CXLs) for acetochlor, afidopyropen, benzovindiflupyr, bifenthrin, boscalid, buprofezin, carbendazim, chlorantraniliprole, cyclaniliprole, cypermethrins (including alpha- and zeta- cypermethrin), dicamba, fenazaquin, flonicamid, fluazifop-P, fluensulfone, flupyradifurone, fluxapyroxad, fosetyl-Al, glyphosate, isofetamid, kresoxim-methyl, mandestrobin, mesotrione, metaflumizone, metconazole, methoprene, pendimethalin, penthiopyrad, picoxystrobin, propiconazole, pydiflumetofen, pyraclostrobin, pyriofenone, pyriproxyfen, spirotetramat, tebuconazole, thiabendazole, tolclofos-methyl and tolfenpyrad.
#2489623
Maidir leis na CXLanna nár chuir an tAontas forchoimeádas ina leith faoi bhráid an Choiste Codex maidir le hIarmhair Lotnaidicídí agus nár shainaithin an tÚdarás imní a d’fhéadfadh a bheith ann ina leith maidir le géar-iontógáil, rud a bhaineann le CXLanna áirithe le haghaidh beinsivindéfhluipire, boscailide, feanascuine, fluasafop-P, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, isifeitimíd, meitipréin, pireaclóstróibine, spiriteitreamat, tiaibeandasóil agus tolclófos-meitile.
The CXLs for which the Union did not present a reservation to the Codex Committee on Pesticides Residues and for which the Authority did not identify a potential acute intake concern, which concern certain CXLs for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl, are safe for consumers in the Union.
#2654248
Rialachán (AE) 2019/50 ón gCoimisiún an 11 Eanáir 2019 lena leasaítear Iarscríbhinní II, III, IV agus V a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil d’iarmhair maidir le clórantrainileapról, clómasón, cioglainileapról, feanasacuin, feinpiococsaimid, fluocsastróibin, lambda-ciahalaitrin, mepiocuat, ola oinniúin, tiaclóiprid agus vailifeanaláit i dtáirgí áirithe nó ar na táirgí sin, arna cheartú le IO L 109, 24.4.2019, lch. 28, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2019/50 of 11 January 2019 amending Annexes II, III, IV and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chlorantraniliprole, clomazone, cyclaniliprole, fenazaquin, fenpicoxamid, fluoxastrobin, lambda-cyhalothrin, mepiquat, onion oil, thiacloprid and valifenalate in or on certain products, as corrected by OJ L 109, 24.4.2019, p. 28, is to be incorporated into the EEA Agreement.
#2770898
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237
#2770918
Maidir leis na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, feanasacuin, fluaipicilíd, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, paclabútrasól, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237, níl an measúnú riosca a rinne na Ballstáit is rapóirtéirí lena mbaineann de bhun Airteagal 11 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 tugtha chun críche go fóill.
For the active substances aclonifen, ametoctradin, beflubutamid, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, fenazaquin, fluopicolide, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, paclobutrazol, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
#2770931
Ós rud é go rachaidh an formheas reatha maidir le cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, feanasacuin, fluaipicilíd, fluraclóradón, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, meataildéad, paclabútrasól, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237 in éag an 31 Bealtaine 2023, ba cheart an Rialachán seo a theacht i bhfeidhm a luaithe is féidir.
Taking into account that the current approval of clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, fenazaquin, fluopicolide, flurochloridone, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, metaldehyde, paclobutrazol, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 expires on 31 May 2023, this Regulation should enter into force as soon as possible.
#2770946
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluaimeatúrón, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd (IO L 238, 21.9.2018, lch. 81).
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (OJ L 238, 21.9.2018, p. 81).
#2893537
Rialachán (AE) 2022/1324 ón gCoimisiún an 28 Iúil 2022 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2022/1324 of 28 July 2022 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products is to be incorporated into the EEA Agreement.
#3037471
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237 (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).
#3043309
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aigéad iondóiliolbútarach, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, feinmeideafam, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, Trichoderma asperellum tréithchineál T34, Trichoderma atroviride tréithchineál I-1237, víreas polaihéadróise núicléach Helicoverpa armigera agus víreas polaihéadróise núicléach Spodoptera littoralis, (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).
#3101169
Rialachán (AE) 2021/1110 ón gCoimisiún an 6 Iúil 2021 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar aimeatochtraidine, bhicsifeine, feanascuine, spineatoram, teafluitrine agus tíoncarbasón-mheitile i dtáirgí áirithe nó ar tháirgí áirithe, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2021/1110 of 6 July 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl in or on certain products is to be incorporated into the EEA Agreement.